The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
Open accessAbstract
Although the innate immune response to induce postischemic inflammation is considered as an essential step in the progression of cerebral ischemia injury, the role of innate immunity mediator NLRP3 in the pathogenesis of ischemic stroke is unknown. In this study, focal ischemia was induced by middle cerebral artery occlusion in NLRP3−/−, NOX2−/−, or wild-type (WT) mice. By magnetic resonance imaging (MRI), Evans blue permeability, and electron microscopic analyses, we found that NLRP3 deficiency ameliorated cerebral injury in mice after ischemic stroke by reducing infarcts and blood–brain barrier (BBB) damage. We further showed that the contribution of NLRP3 to neurovascular damage was associated with an autocrine/paracrine pattern of NLRP3-mediated interleukin-1 β (IL-1 β) release as evidenced by increased brain microvessel endothelial cell permeability and microglia-mediated neurotoxicity. Finally, we found that NOX2 deficiency improved outcomes after ischemic stroke by mediating NLRP3 signaling. This study for the first time shows the contribution of NLRP3 to neurovascular damage and provides direct evidence that NLRP3 as an important target molecule links NOX2-mediated oxidative stress to neurovascular damage in ischemic stroke. Pharmacological targeting of NLRP3-mediated inflammatory response at multiple levels may help design a new approach to develop therapeutic strategies for prevention of deterioration of cerebral function and for the treatment of stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Hu, X., Li, P., Guo, Y., Wang, H., Leak, R. K., Chen, S., Gao, Y., & Chen, J. (2012) · Stroke · doi:10.1161/strokeaha.112.659656 · Cited by 1,535
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K. L., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 732
NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke
Kahles, T., Luedike, P., Endres, M., Galla, H.-J., Steinmetz, H., Busse, R., Neumann-Haefelin, T., & Brandes, R. P. (2007) · Stroke · doi:10.1161/strokeaha.107.489765 · Cited by 386
Kleinschnitz, C., Kraft, P., Dreykluft, A., Hagedorn, I., Göbel, K., Schuhmann, M. K., Langhauser, F., Helluy, X., Schwarz, T., Bittner, S., et al. (2013) · Blood · doi:10.1182/blood-2012-04-426734 · Cited by 354
Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra
Kaushal, V., & Schlichter, L. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5643-07.2008 · Cited by 346
NF‐κB and innate immunity in ischemic stroke
Harari, O. A., & Liao, J. K. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05735.x · Cited by 311
Inhibition of NADPH Oxidase is Neuroprotective after Ischemia—Reperfusion
Chen, H., Song, Y. S., & Chan, P. H. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.47 · Cited by 286
The neurovascular unit in the setting of stroke
Del Zoppo, G. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02199.x · Cited by 285
Meissner, F., Seger, R. A., Moshous, D., Fischer, A., Reichenbach, J., & Zychlinsky, A. (2010) · Blood · doi:10.1182/blood-2010-01-264218 · Cited by 269
Wang, Z., Leng, Y., Tsai, L.-K., Leeds, P., & Chuang, D.-M. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.195 · Cited by 230
Self-citationSignalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR
Doller, A., Pfeilschifter, J., & Eberhardt, W. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.05.007 · Cited by 215
Pathobiology of injury after stroke: the neurovascular unit and beyond
Dirnagl, U. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06691.x · Cited by 212
Hayakawa, K., Pham, L.-D. D., Katusic, Z. S., Arai, K., & Lo, E. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121146109 · Cited by 187
Vascular mechanisms in the pathogenesis of stroke.
Sierra, C., Coca, A., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0195-x · Cited by 162
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Di Virgilio, F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006171 · Cited by 161
Regulation of innate immunity by NADPH oxidase
Segal, B. H., Grimm, M. J., Khan, A. N. H., Han, W., & Blackwell, T. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.022 · Cited by 153
Osada, T., Gu, Y.-H., Kanazawa, M., Tsubota, Y., Hawkins, B. T., Spatz, M., Milner, R., & del Zoppo, G. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.99 · Cited by 150
Abais, J. M., Zhang, C., Xia, M., Liu, Q., Gehr, T. W. B., Boini, K. M., & Li, P. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4666 · Cited by 148
Yang, Y., Thompson, J. F., Taheri, S., Salayandia, V. M., McAvoy, T. A., Hill, J. W., Yang, Y., Estrada, E. Y., & Rosenberg, G. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.56 · Cited by 147
Innate instruction of adaptive immunity revisited: the inflammasome
Eisenbarth, S. C., & Flavell, R. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900014 · Cited by 136
Which NADPH Oxidase Isoform Is Relevant for Ischemic Stroke? The Case for Nox 2
Kahles, T., & Brandes, R. P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4721 · Cited by 125
Ludewig, P., Sedlacik, J., Gelderblom, M., Bernreuther, C., Korkusuz, Y., Wagener, C., Gerloff, C. P., Fiehler, J., Magnus, T. U., & Horst, A. K. (2013) · Circulation Research · doi:10.1161/circresaha.113.301207 · Cited by 123
Redox control of NLRP3 inflammasome activation in health and disease
Rubartelli, A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512265 · Cited by 117
Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Maki, T., Hayakawa, K., Pham, L. D., Xing, C., Lo, E. H., & Arai, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030004 · Cited by 112
The neurovascular unit, matrix proteases, and innate inflammation
del Zoppo, G. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05760.x · Cited by 111
TIPE2, a Novel Regulator of Immunity, Protects against Experimental Stroke
Zhang, Y., Wei, X., Liu, L., Liu, S., Wang, Z., Zhang, B., Fan, B., Yang, F., Huang, S., Jiang, F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348755 · Cited by 86
Self-citationThe machinery of Nod‐like receptors: refining the paths to immunity and cell death
Saleh, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01045.x · Cited by 84
He, M. Y., Zhang, B., Wei, X., Wang, Z., Fan, B., Du, P., Zhang, Y., Jian, W., Chen, L., Wang, L., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12040 · Cited by 77
Self-citationLee, K. Y., Bae, O., Serfozo, K., Hejabian, S., Moussa, A., Reeves, M. J., Rumbeiha, W. K., Fitzgerald, S. D., Stein, G., Baek, S., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.639427 · Cited by 62
Wang, Z., Wei, X., Liu, K., Zhang, X., Yang, F., Zhang, H., He, Y., Zhu, T., Li, F., Shi, W., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.166 · Cited by 59
Self-citationLin, W., Lin, C., Cheng, H. K., & Yang, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01312.x · Cited by 54
Novel Role of NOD2 in Mediating Ca 2+ Signaling
Han, H., Wang, Y., Li, X., Wang, P., Wei, X., Liang, W., Ding, G., Yu, X., Bao, C., Zhang, Y., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01638 · Cited by 36
Self-citationNOX Inhibitors as a Therapeutic Strategy for Stroke and Neurodegenerative Disease
Cairns, B., Kim, J. Y., Tang, X. N., & Yenari, M. A. (2012) · Current Drug Targets · doi:10.2174/138945012799201676 · Cited by 31
Fernández‐Cadenas, I., Río-Espínola, A. D., Giralt, D., Domingues‐Montanari, S., Quiroga, A. G., Mendióroz, M., Ruiz, A., Ribó, M., Serena, J. L., Obach, V., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.657007 · Cited by 30
Inflammasome Activation in Reperfusion Injury
Grundmann, S., Bode, C., & Moser, M. (2011) · Circulation · doi:10.1161/circulationaha.111.018176 · Cited by 15
Cited by
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
Self-citationInflammasome signalling in brain function and neurodegenerative disease
Heneka, M. T., McManus, R. M., & Latz, E. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0055-7 · Cited by 836
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
Metadata
- Authors
- Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., & Yi, F.
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2014-01-15
- Volume
- 34
- Issue
- 4
- Pages
- 660-667
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2019260483
- Cited by
- 422
- References
- 39
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.